PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Announces Investment in Spine BioPharma

20 Apr 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology

14 Apr 2021 16:00:00 By Nasdaq GlobeNewswire

Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021

07 Apr 2021 08:00:00 By Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients

22 Mar 2021 18:42:22 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021

09 Mar 2021 08:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

03 Mar 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results

25 Feb 2021 08:00:03 By Nasdaq GlobeNewswire

Pacira to Report 2020 Financial Results on Thursday February 25, 2021

18 Feb 2021 07:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021

10 Feb 2021 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics

26 Jan 2021 08:00:01 By Nasdaq GlobeNewswire